Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Blood ; 135(23): 2071-2084, 2020 06 04.
Artigo em Inglês | MEDLINE | ID: mdl-31990287

RESUMO

Sickle cell disease (SCD) is a monogenic red blood cell (RBC) disorder with high morbidity and mortality. Here, we report, for the first time, the impact of SCD on the bone marrow (BM) vascular niche, which is critical for hematopoiesis. In SCD mice, we find a disorganized and structurally abnormal BM vascular network of increased numbers of highly tortuous arterioles occupying the majority of the BM cavity, as well as fragmented sinusoidal vessels filled with aggregates of erythroid and myeloid cells. By in vivo imaging, sickle and control RBCs have significantly slow intravascular flow speeds in sickle cell BM but not in control BM. In sickle cell BM, we find increased reactive oxygen species production in expanded erythroblast populations and elevated levels of HIF-1α. The SCD BM exudate exhibits increased levels of proangiogenic growth factors and soluble vascular cell adhesion molecule-1. Transplantation of SCD mouse BM cells into wild-type mice recapitulates the SCD vascular phenotype. Our data provide a model of SCD BM, in which slow RBC flow and vaso-occlusions further diminish local oxygen availability in the physiologic hypoxic BM cavity. These events trigger a milieu that is conducive to aberrant vessel growth. The distorted neovascular network is completely reversed by a 6-week blood transfusion regimen targeting hemoglobin S to <30%, highlighting the plasticity of the vascular niche. A better insight into the BM microenvironments in SCD might provide opportunities to optimize approaches toward efficient and long-term hematopoietic engraftment in the context of curative therapies.


Assuntos
Anemia Falciforme/complicações , Transfusão de Sangue/métodos , Medula Óssea/patologia , Eritrócitos Anormais/patologia , Hematopoese , Neovascularização Patológica/prevenção & controle , Esplenomegalia/prevenção & controle , Animais , Medula Óssea/metabolismo , Eritrócitos Anormais/metabolismo , Feminino , Humanos , Masculino , Camundongos , Neovascularização Patológica/etiologia , Neovascularização Patológica/patologia , Esplenomegalia/etiologia , Esplenomegalia/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...